Combined tests provide most data for Alzheimer's diagnosis

12/11/2012 |

Combining MRI, FDG-PET and cerebrospinal fluid analysis provided the most data for diagnosing Alzheimer's disease and allowed researchers to achieve the lowest misclassification rate of 28.4% when compared with neuropsychological testing, according to a study by Duke Medicine researchers. They also observed that of the three methods, FDG-PET provided the most data for use in diagnosing early Alzheimer's in people with mild cognitive impairment. More studies are needed to further understand the use of the tests in the clinical environment, researchers said.

View Full Article in:

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Financial Officer
B. E. Smith
Miramar, FL
Claims Director
Springfield, OR
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA